According to Dare Bioscience 's latest financial reports and stock price the company's current Operating Margin is -119.08%. At the end of 2016 the company had an Operating Margin of -4,839.16%.
Year | Operating Margin | Change |
---|---|---|
2016 | -4,839.16% | |
2014 | -27,823.75% | -89.34% |
2013 | -260,933.33% | 7473.29% |
2012 | -3,445.44% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
![]() ORIC Pharmaceuticals
ORIC | 0.00% | N/A | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.